Browse All
Displaying 606 - 610 of 1714
Author:Darras, Basil Mercuri, Eugenio Strauss, Kevin Day, John Chien, Yin-Hsiu Masson, Ricardo Wigderson, Melissa Alecu, Iulian Ballarini, Nicolas Mehl, Lesa Marra, Jonathan Connolly, Anne
Session Name:S34: Child Neurology and Developmental Neurology 2
Topic:Child Neurology and Developmental Neurology
Program Number:S34.002
Author Institution:Boston Children’s Hospital, Harvard Medical School, Boston, MA Department of Paediatric Neurology and Nemo Clinical Centre, Catholic University, Rome, Italy Clinic for Special Children, Strasburg, PA Stanford University School of Medicine, Palo Alto, CA National Taiwan University Hospital, Taipei City, Taiwan Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy Novartis Gene Therapies, Inc., Bannockburn, IL Novartis Pharmaceuticals, Basel, Switzerland Novartis Institutes for BioMedical Research, Cambridge, MA Novartis Pharmaceuticals, East Hanover, NJ Center for Gene Therapy, Nationwide Children's Hospital, Columbus, OH
Author:Jayaraman, Divya Genetti, Casie Aykanat, Asli Win, Wathone Valivullah, Zaheer O'Heir, Emily Darras, Basil Laine, Regina O'Donnell-Luria, Anne Beggs, Alan
Session Name:N4: Neuroscience in the Clinic: Bridging Genetics to the Clinic in Neuromuscular Disease
Topic:Neuromuscular and Clinical Neurophysiology (EMG)
Program Number:N4.003
Author Institution:Boston Children’s Hospital, Boston, MA Broad Institute of MIT and Harvard, Boston, MA Boston Children's Hospital, Boston, MA Boston Children’s Hospital/Broad Institute of Harvard and MIT, Boston, MA Boston Children's Hospital/Harvard Medical School, Boston, MA
Author:McGrattan, Katlyn Shell, Richard Hurst-Davis, Rebecca Dunaway Young, Sally Baranello, Giovanni Lavrov, Arseniy O'Brien, Eamonn Wallach, Shiri LaMarca, Nicole Reyna, Sandra P. Darras, Basil
Session Name:P7: Child Neurology and Developmental Neurology: Spinomuscular Atrophy/Muscular Dystrophies
Program Number:P7.008
Author Institution:University of minnesota, Minneapolis, MN Nationwide Children’s Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH Primary Children’s Hospital, Salt Lake City, UT Stanford University School of Medicine, Stanford, CA The Dubowitz Neuromuscular Centre, Developmental Neuroscience Research and Teaching Department, UCL Great Ormond Street Institute of Child Health and NIHR Great Ormond Street Hospital Biomedical Research Centre & Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom Novartis Gene Therapies, Inc., Cambridge, United Kingdom Novartis, Dublin, Ireland Novartis Gene Therapies, Inc., Bannockburn, IL Boston Children’s Hospital, Harvard Medical School, Boston, MA
Author:Darras, Basil Baranello, Giovanni Boespflug-Tanguy, Odile Day, John Deconinck, Nicholas Klein, Andrea Masson, Ricardo Mazurkiewicz-Beldzinska, Maria Mercuri, Eugenio Rose, Kristy Vlodavets, Dmitry Xiong, Hui Zanoteli, Edmar El-Khairi, Muna Gerber, Marianne Gorni, Ksenija Kletzl, Heidemarie Palfreeman, Laura Dodman, Angela Servais, Laurent
Program Number:P7.009
Author Institution:Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA, Boston, MA Dubowitz Neuromuscular Centre, University College London, London, UK Developmental Neurology, Istituto Neurologico C Besta, Milan, Italy, London, United Kingdom IMotion Institut de Myologie AP-HP, Hôpital Armand Trousseau, Paris, France Université Paris Cité, UMR 1141, NeuroDiderot, Paris, France, Paris, France Stanford University, Palo Alto, CA, USA, Palo Alto, CA Neuromuscular Center, UZ Gent, Ghent, Belgium Centre de Référence des Maladies Neuromusculaires, Children’s University Hospital, ULB, Brussels, Belgium, Ghent, Belgium Paediatric Neurology, Uni. Children’s Hospital Basel, Basel, Switzerland Paediatric Neurology, Inselspital, University of Bern, Bern, Switzerland, Basel, Switzerland Developmental Neurology, Istituto Neurologico C Besta, Milan, Italy, Milan, Italy Developmental Neurology, Medical University of Gdansk, Gdansk, Poland, Gdansk, Poland Pediatric Neurology Institute, Catholic University, Rome, Italy, Rome, Italy Paediatric Gait Analysis Service of New South Wales, The Children’s Hospital at Westmead, Sydney, Australia, Sydney, Australia Children Neuromuscular Center, Pirogov Medical University, Moscow, Russia, Moscow, Russian Federation Department of Pediatrics, Peking University First Hospital, Beijing, China, Beijing, China, People's Republic of Department of Neurology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, Sao Paulo, Brazil Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom Pharma Development, Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland PDMA Neuro/Rare Disease, F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland Pharmaceutical Research, Roche Innovation Center Basel, Basel, Switzerland, Basel, Switzerland Pharma Development Neuro, F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland MDUK Oxford Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, UK Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University of Liège, Liège, Belgium, Oxford, United Kingdom
Author:Zaidman, Craig Proud, Crystal McDonald, Craig Mason, Stefanie Guridi, Maitea Wang, Shufang Reid, Carol Darton, Eddie Wandel, Christoph Lewis, Sarah Malhotra, Jyoti Griffin, Danielle Potter, Rachael Rodino-Klapac, Louise Mendell, Jerry
Session Name:S48: Therapeutics for Muscle Disease
Program Number:S48.003
Author Institution:Department of Neurology, WUSTL, Washington, MO Children’s Hospital of the King’s Daughters, Norfolk, VA UC Davis Health, Sacramento, CA Sarepta Therapeutics, Inc. , Cambridge, MA F. Hoffmann-La Roche Ltd, Basel, Switzerland Roche Products Ltd, Welwyn Garden City, United Kingdom Center for Gene Therapy, Nationwide Children’s Hospital, Columbus, OH
